“The partnership model GTP has pioneered is delivering novel treatment options to underserved disease populations and is creating exciting new avenues for academic research funding.”
Lori Kellam is a Project Manager in the Gene Therapy Program. She facilitates the transition of exploratory and preclinical gene therapy research to clinically meaningful research that enables submissions of Investigational New Drug applications to the FDA. She coordinates and supports the internal scientific team in addition to maintaining strong and transparent partnerships with external Sponsors.
Lori earned a PhD in Molecular Genetics from the University of Florida in 2006 and followed with post-doctoral research at Temple University and the University of Pennsylvania, where she worked to develop innovative strategies for cell-based therapies of infertility and is the author of 4 peer-reviewed scientific publications.
Learn more about our staff and scientists.